Cargando…
IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment
Homotaurine is a potential therapeutic compound for treatment of Alzheimer’s disease (AD), but its efficacy is still under investigation. Emerging data have shown that other than neuroprotective, homotaurine is endowed with anti-inflammatory activities, though with still unclear underlying mechanism...
Autores principales: | Toppi, Elisa, Sireno, Laura, Lembo, Micaela, Banaj, Nerisa, Messina, Beatrice, Golesorkhtafti, Sedigheh, Spalletta, Gianfranco, Bossù, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9061963/ https://www.ncbi.nlm.nih.gov/pubmed/35515001 http://dx.doi.org/10.3389/fimmu.2022.813951 |
Ejemplares similares
-
Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment
por: Bossù, Paola, et al.
Publicado: (2018) -
Editorial: Insights in Aging Psychiatry: 2021
por: Spalletta, Gianfranco, et al.
Publicado: (2022) -
Identification of Genetic Networks Reveals Complex Associations and Risk Trajectory Linking Mild Cognitive Impairment to Alzheimer’s Disease
por: Strafella, Claudia, et al.
Publicado: (2022) -
Implication of Aging Related Chronic Neuroinflammation on COVID-19 Pandemic
por: Bossù, Paola, et al.
Publicado: (2020) -
Editorial: Cognitive, Psychological, and Psychiatric Consequences of the Coronavirus (COVID-19) Pandemic in the Population of Older Persons With Cognitive Impairment, Dementia, and/or Neuropsychiatric Disorders
por: Palmer, Katie, et al.
Publicado: (2021)